Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Inazu

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Lipids in Health and Disease|April 4, 2016
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapyHayato Tada, Junji Kobayashi, Masa-Aki Kawashiri, et al.
Journal of Atherosclerosis and Thrombosis|February 7, 2014
Relationships between alanine aminotransferase (ALT), visceral adipose tissue (AT) and metabolic risk factors in a middle-aged Japanese populationRie Oka, Kunimasa Yagi, Chiaki Nakanishi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 11, 2020
Serum sitosterol level predicting ABCG5 or ABCG8 genetic mutationsNobuko Kojima, Hayato Tada, Soichiro Usui, et al.
Journal of Atherosclerosis and Thrombosis|December 29, 2006
Cholesterol-years score is associated with development of senile degenerative aortic stenosis in heterozygous familial hypercholesterolemiaTsuyoshi Nozue, Masa-Aki Kawashiri, Toshinori Higashikata, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 2011
Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover studyMasa-aki Kawashiri, Junji Kobayashi, Atsushi Nohara, et al.
Journal of Atherosclerosis and Thrombosis|August 30, 2016
Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012Hayato Tada, Masa-Aki Kawashiri, Atsushi Nohara, et al.
Atherosclerosis|December 17, 2009
The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulationTohru Noguchi, Shoji Katsuda, Masa-Aki Kawashiri, et al.
Clinical Science (London, England : 1979)|April 9, 2005
ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjectsKenji Miwa, Akihiro Inazu, Junji Kobayashi, et al.
Atherosclerosis|June 6, 2002
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemiaYoshihiro Noji, Toshinori Higashikata, Akihiro Inazu, et al.
Metabolism: Clinical and Experimental|November 21, 2009
Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese menRie Oka, Junji Kobayashi, Akihiro Inazu, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Lipids in Health and Disease|April 4, 2016
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapyHayato Tada, Junji Kobayashi, Masa-Aki Kawashiri, et al.
Journal of Atherosclerosis and Thrombosis|February 7, 2014
Relationships between alanine aminotransferase (ALT), visceral adipose tissue (AT) and metabolic risk factors in a middle-aged Japanese populationRie Oka, Kunimasa Yagi, Chiaki Nakanishi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 11, 2020
Serum sitosterol level predicting ABCG5 or ABCG8 genetic mutationsNobuko Kojima, Hayato Tada, Soichiro Usui, et al.
Journal of Atherosclerosis and Thrombosis|December 29, 2006
Cholesterol-years score is associated with development of senile degenerative aortic stenosis in heterozygous familial hypercholesterolemiaTsuyoshi Nozue, Masa-Aki Kawashiri, Toshinori Higashikata, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 2011
Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover studyMasa-aki Kawashiri, Junji Kobayashi, Atsushi Nohara, et al.
Journal of Atherosclerosis and Thrombosis|August 30, 2016
Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012Hayato Tada, Masa-Aki Kawashiri, Atsushi Nohara, et al.
Atherosclerosis|December 17, 2009
The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolaemia by increasing PCSK9 function and concentration in the circulationTohru Noguchi, Shoji Katsuda, Masa-Aki Kawashiri, et al.
Clinical Science (London, England : 1979)|April 9, 2005
ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjectsKenji Miwa, Akihiro Inazu, Junji Kobayashi, et al.
Atherosclerosis|June 6, 2002
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemiaYoshihiro Noji, Toshinori Higashikata, Akihiro Inazu, et al.
Metabolism: Clinical and Experimental|November 21, 2009
Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese menRie Oka, Junji Kobayashi, Akihiro Inazu, et al.
Pageof 9